Niklas Beyhoff
MD
Clinical Research Fellow
Niklas completed his medical doctorate at Charité - Universitätsmedizin Berlin in Germany, where he received the Robert Koch award for the annual best thesis. Since 2020, he pursued clinical training in cardiology at the Heart Center of Charité and the German Heart Institute Berlin.
Niklas' primary research interest lays in advanced imaging modalities and myocardial metabolism in cardiovascular diseases. He received funding by the German Centre for Cardiovascular Research and the German Cardiac Society. Niklas has been honoured with different awards including a nomination to attend the Lindau Nobel Laureate meeting as one of 600 young scientists from around the world.
Since April 2023, Niklas is a Clinical Research Fellow in Cardiovascular Medicine at the Radcliffe Department of Medicine (group of Prof Stefan Neubauer). Here, he uses novel cardiac MRI modalities to improve differentiation and characterization of left-ventricular hypertrophy in a prospective clinical study. An additional focus is to foster the cooperation between the University of Oxford and his home institution via the Oxford Berlin Research Partnership.
Recent publications
Left Atrial Reservoir Strain Predicts Atrial Fibrillation in Hypertrophic Cardiomyopathy: Insights from the NHLBI HCM Registry.
Journal article
Beyhoff N. et al, (2026), JACC Cardiovasc Imaging, 19, 133 - 135
Defining HFpEF in rodents: a systematic review.
Journal article
Adrah Y. et al, (2025), Cardiovasc Res, 121, 2134 - 2143
Cancer therapy-related cardiotoxicity is associated with distinct alterations of the myocardial lipidome.
Journal article
Braun VM. et al, (2025), Eur J Heart Fail, 27, 1056 - 1066
Characterization of anthracycline-induced cardiotoxicity by diffusion tensor magnetic resonance imaging.
Journal article
Lohr D. et al, (2025), Basic Res Cardiol, 120, 57 - 69
Multiparametric cardiovascular magnetic resonance evaluation of myocardial perfusion, oxygenation, and energetics in hypertrophic cardiomyopathy following cardiac myosin inhibitor therapy.
Journal article
Finnigan LEM. et al, (2025), Eur Heart J Cardiovasc Imaging, 26
